KLRC1 and acute myeloid leukemia: For instance, using flow cytometry panels similar to those presented above, NKG2A alterations have been reported in ILC1-like cytotoxic cells in acute myeloid leukemia, accounting for impaired killing capacity by these cells in patients (67).